Tecan Group AG · SIX:TECN
Tecan — UBS Virtual Global Healthcare Conference 2020
23 slides from Tecan's conference presentation, May 18, 2020
Slide 1: UBS Virtual Global Healthcare Conference
Tecan Group UBS Virtual Global Healthcare Conference DR. ACHIM VON LEOPRECHTING, CEO MAY 18-19, 2020
Slide 2: Safe Harbor Statement
Safe Harbor Statement All statements in this presentation not referring to historical facts are predictions of the future and constitute no guarantee whatsoever of future performances. They are subject to risks and uncertainties including, but not limited to, future global economic conditions, excha
Slide 3: Empowering the Century of Biology
Empowering the Century of Biology. v 42 z2 zy 52
Slide 4: Tecan is Benefitting from Multiple Megatrends
Tecan is Benefitting from Multiple Megatrends 5 key trends… …fuel need for lab automation Population growth and the aging population Increasing test volumes High levels of investment in healthcare and life science research in emerging markets Increasing needs • Productivity Development of targeted p
Slide 5: Megatrends Translating into Growth Opportunities
Megatrends Translating into Growth Opportunities SUCCESSFUL FINANCIAL PERFORMANCE IN RECENT YEARS SALES DEVELOPMENT OPERATING PROFIT (EBITDA) 636.8 650 Total: +64% 130 Total: +89% 122.8 593.8 CAGR: +11.2% 600 CAGR: +8.6% 120 548.6 110.3 550 110 104.6 506.2 500 100 440.3 89.0 450 90 83.4 388.3 399.5
Slide 6: Tecan Competencies Empowering the Century of Biology
Tecan Competencies Empowering the Century of Biology FROM DISCOVERY OF NOVEL MEDICATIONS ALL THE WAY TO BETTER DIAGNOSIS OF DISEASES HEALTHCARE USE APPLICATIONS TECAN’S ENABLING COMPETENCIES Better… • Genomics • Applications and Workflows • understand • Protein analysis • Robotics and Automation Can
Slide 7: Tecan's Vision Statement
Tecan’s Vision Statement Our vision is to empower every laboratory, every day, around the world with Tecan technology, products and support. We will help to shape the future of automated workflows in life sciences and clinical diagnostics through unrivaled expertise, products and customer support. 7
Slide 8: Introducing Tecan
Introducing Tecan • Pioneer and global leader in laboratory automation, in 2020 we are celebrating our 40th birthday! • Our solutions accelerate, automate and enhance the processes in state-of-the-art diagnostics and life sciences labs • Offering solutions in select application areas: • Immunoassays
Slide 9: Tecan's Products, Business Structure and Markets
Tecan’s Products, Business Structure and Markets •LIFE SCIENCES Life Sciences BUSINESS Business •PARTNERING BUSINESS Partnering Business • Focused on all end-user activities • Focused on all OEM activities • Products marketed under the Tecan brand through • Products sold by partners under their own
Slide 10: Growth Drivers & Product Launches
Growth Drivers & Product Launches
Slide 11: Continuing to Deploy Successful Corporate Strategy
Continuing to Deploy Successful Corporate Strategy FOCUSING ON HIGHER GROWTH AREAS AND REGIONS – COMPLEMENTED BY M&A LIFE SCIENCE RESEARCH IN-VITRO DIAGNOSTICS STRATEGIC PILLARS CAGR +3-5% +3-5% >55 BN USD >60 BN USD 1 Scale & capability 2 Build additional pillars and complete portfolio 3 Offer solu
Slide 12: Transition from Research to Diagnostics
Transition from Research to Diagnostics TECAN HAS A UNIQUE POSITION TO BRIDGE FROM RESEARCH TO DIAGNOSTICS SETTINGS LIFE SCIENCE RESEARCH LAB DEVELOPED TESTS (LDT) IN-VITRO DIAGNOSTICS Life Sciences Life Sciences Partnering Business Business Business Covering individual steps of a Sample-to-Result S
Slide 13: Partner of Choice to the IVD Industry
Partner of Choice to the IVD Industry PARTNERING BUSINESS BROAD BASE OF ACTIVE INSTRUMENT ACCOUNTS, MULTIPLE DEVELOPMENTS IN PROGRESS IN REGULAR SUPPLY PHASE NEWLY LAUNCHED UNDER DEVELOPMENT INSTRUMENT PIPELINE 35+ different instruments supplied 5+ projects under 25+ concrete concepts in development
Slide 14: Offering More Comprehensive Workflow Solutions
Offering More Comprehensive Workflow Solutions LIFE SCIENCES BUSINESS COMBINING AUTOMATION, DETECTION, SOFTWARE, CONSUMABLES AND REAGENTS FOR GENOMICS GENOMICS / NGS WORKFLOW STEPS EMPOWERING APPLICATIONS: FLUENT’S DNA 2019: DREAMPREP NGS 2020: DREAMPREP NAP 1 Sample collection 2 Sample identificati
Slide 15: Strategic Focus on Recurring Revenues
Strategic Focus on Recurring Revenues APPLICATION FOCUS AND SOLUTIONS OFFERING KEY DRIVERS OF CONSUMABLES AND REAGENT GROWTH TOTAL RECURRING CONSUMABLES REAGENTS REVENUES 2013 34% 66% FUNCTIONAL CONSUMABLES SERVICES, SPARE PARTS & SOFTWARE 2019 41% 59% 15
Slide 16: Financials and Outlook
¥ Financials and O I l ] I I ] I I I TECAN
Slide 17: New Coronavirus Sars-CoV-2 and COVID-19
New Coronavirus Sars-CoV-2 and COVID-19 SUPPORTING OUR CUSTOMERS AND PARTNERS IN FIGHTING THE OUTBREAK AND DISEASE RESEARCH CLINICAL TESTING 1 • Supporting customers with automation solutions and • In Q1 mostly supporting local IVD companies in China and reagents, mainly in research and drug discove
Slide 18: Delivering Accelerated Growth
Delivering Accelerated Growth REFINED STRATEGY AND ITS DEPLOYMENT PAYING OFF SALES DEVELOPMENT • Sales up by 64% since 2013 (CAGR 8.6% in CHF, +8.9% in LC) 650 637 600 CAGR: +8.6% 594 • Around two thirds of the increase derived (+8.9% in LC) 549 from organic growth 550 506 500 • Major new instrument
Slide 19: Financial Outlook for 2020
Financial Outlook for 2020 SALES DEVELOPMENT SALES OUTLOOK 700 Growth in MSD to • Forecast for growth in local currencies in the mid- to high 650 636.8 HSD range in LC1 single-digit percentage range, as in 2019 593.8 600 • Assuming an even higher share from organic growth CHF (mio) 548.6 550 500 506
Slide 20: Empowering the Century of Biology
Empowering the Century of Biology. v 42 z2 zy 52 @TECAN.
Slide 21: Celebrating 40 years of Tecan
UW) < LO A Se Celebrating 40 years of Tecan. a PIPEITPIP PPP Pb bbb bb bbe eee) @TECAN.
Slide 22: Slide 22
Slide 23: Tecan – Who we are
Tecan – Who we are Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the lif
Tecan Group — UBS Virtual Global Healthcare Conference 2020 on 6ix